• Home
  • Search Results
  • A method for rapid screening of interactions of pharmacologically active compounds with albumin.

A method for rapid screening of interactions of pharmacologically active compounds with albumin.

Analytica chimica acta (2014-12-30)
Aldona Majcher, Anna Lewandrowska, Franciszek Herold, Jacek Stefanowicz, Tomasz Słowiński, Aleksander P Mazurek, Stefan A Wieczorek, Robert Hołyst

We determine the association constants for ligand-protein complex formation using the flow injection method. We carry out the measurements at high flow rates (F=1 mL min(-1)) of a carrier phase. Therefore, determination of the association constant takes only a few minutes. Injection of 1 nM of the ligand (10 μL of 1 μM concentration of the ligand solution) is sufficient for a single measurement. This method is tested and verified for a number of complexes of selected drugs (cefaclor, etodolac, sulindac) with albumin (BSA). We obtain K=4.45×10(3) M(-1) for cefaclor, K=1.00×10(5) M(-1) for etodolac and K=1.03×10(5) M(-1) for sulindac in agreement with the literature data. We also determine the association constants of 20 newly synthesized 3β- and 3α-aminotropane derivatives with potential antipsychotic activity--ligands of 5-HT1A, 5-HT2A and D2 receptors with the albumin. Results of the studies reported here indicate that potential antipsychotic drugs bind weakly to the transporter protein (BSA) with K≈10(2)-10(3) M(-1). Our method allows measuring K in a wide range of values (10(2)-10(9) M(-1)). This range depends only on the solubility of the ligand and sensitivity of the detector.

Product Number
Product Description

Methylamine solution, 33 wt. % in absolute ethanol ((denatured with 1% toluene))
Methylamine solution, 2.0 M in THF
Methylamine solution, 2.0 M in methanol
Sulindac, ≥98.0%
Cefaclor, Pharmaceutical Secondary Standard; Certified Reference Material
Cefaclor, United States Pharmacopeia (USP) Reference Standard
Etodolac for peak identification, European Pharmacopoeia (EP) Reference Standard
Sulindac, European Pharmacopoeia (EP) Reference Standard
Etodolac, European Pharmacopoeia (EP) Reference Standard
Sulindac, meets USP testing specifications

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.